The round was led by existing investor Anzu Partners with participation from Entegris, a global leader in advanced materials science, and fellow existing investor, RA Capital Management. TeraPore will leverage the funding to launch its IsoBlock™ virus filter and expand the use of its core technology into new high value markets.

TeraPore Technologies develops high-permeability, high-resolution membrane nanofiltration systems for bioprocessing and other applications. Its mission is to solve the most challenging bioseparation problems.